Could a tiny dose of an alcoholism drug ease vasculitis pain?
NCT ID NCT03482479
First seen Jan 23, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tested whether a very low dose of naltrexone, a drug already approved for alcoholism, can improve physical health and quality of life in people with vasculitis (a group of rare diseases causing blood vessel inflammation). Sixty adults with different types of vasculitis took either the low-dose naltrexone or a placebo. The goal was to see if the drug could reduce pain and improve daily functioning better than a sugar pill.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
St. Joseph's Healthcare
Hamilton, Ontario, Canada
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
-
University of Utah
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.